Table 2.
Treatment-related adverse events occurring in ≥10% of patients
| Adverse event | Any grade, N (%) | Grade III–IV, N (%) |
|---|---|---|
| Thrombocytopenia | 24 (62) | 16 (41) |
| Diarrhea | 19 (49) | 2 (5) |
| Nausea | 18 (46) | 1 (3) |
| Fatigue | 14 (36) | 2 (5) |
| Decreased appetite | 7 (18) | — |
| AST elevation | 7 (18) | 3 (8) |
| Neutropenia | 6 (15) | 4 (10) |
| ALT elevation | 6 (15) | 3 (8) |
| Dehydration | 4 (10) | 2 (5.1) |
| Dyspepsia | 4 (10) | — |
| Dysgeusia | 4 (10) | — |
NOTE: Adverse events possibly, probably, or definitely related are included.
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase.